Article Information
History
- June 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Steven J Lubbe1,
- Bernabe Bustos1,
- Jing Hu1,
- Dimitri Krainc1,
- Theresita Joseph2,
- Jason Hehir3,
- Manuela Tan2,
- Weijia Zhang2,
- Valentina Escott-Price4,
- Nigel M Williams4,
- Cornelis Blauwendraat5,
- Andrew B Singleton5,
- Huw R Morris2,*,
- for International Parkinson’s Disease Genomics Consortium (IPDGC)6
- 1Ken and Ruth Davee Department of Neurology, and Simpson Querrey Center for Neurogenetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
- 2Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK and UCL Movement Disorders Centre, UCL Queen Square Institute of Neurology
- 3National Hospital for Neurology and Neurosurgery, Queens Square, London, UK
- 4Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine, Cardiff, UK
- 5Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
- ↵*CORRESPONDING AUTHOR
Professor Huw R. Morris, Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, London, NW3 2PF, United Kingdom., Email: h.morris{at}ucl.ac.uk, Telephone: +44 (0)20 7830 2951
Posted June 28, 2020.
ASSESSING THE RELATIONSHIP BETWEEN MONOALLELIC PARK2 MUTATIONS AND PARKINSON’S RISK
